Skip to main content
SpringerLink
Log in

The use of nephrotoxic drugs in patients with chronic kidney disease

  • Research Article
  • Published:
International Journal of Clinical Pharmacy Aims and scope Submit manuscript

Abstract

Background The use of nephrotoxic drugs has the potential to accelerate the loss of kidney function and increase the risk of end-stage renal disease. Objectives To determine the prevalence of nephrotoxic drugs use in patients with chronic kidney disease at two major hospitals in Maiduguri and to evaluate the predictors of exposure to the contraindicated ones. Methods This retrospective study used data from the patients’ medical records. Patients aged ≥ 18 years that were diagnosed with chronic kidney disease from 2013 to 2017 with documented serum creatinine levels for the period under review were included in the study. Descriptive statistics were used to summarize the socio-demographics, clinical and biochemical characteristics of the study population. Predictors of nephrotoxic, and contraindicated nephrotoxic medication exposure were assessed using Chi square and logistic regression tests respectively. Results The results are based on data from 201 patients. Of these, 96.0% received at least one prescription of a nephrotoxic drug within the period under review. Multivariate logistic regression showed that the odds of receiving the seven contraindicated nephrotoxic drugs increased in those aged 60 years or older (OR 8.00, 95% CI 1.67–38.40), and those with mild/moderate chronic kidney disease (OR 3.51, 95% CI 1.14–10.77). Main Outcome Measure Prevalence of nephrotoxic drug exposure in patients with chronic kidney disease. Conclusions Large proportions of patients with chronic kidney disease received nephrotoxic drugs, mainly diuretics. However, patients aged 60 years or older, and those at chronic kidney disease stages 2–3 were significantly more likely to receive contraindicated nephrotoxic drugs compared to other age groups and chronic kidney disease stages.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Bamgboye E. 17,000 kidney failure cases diagnosed annually in Nigeria. 2016. https://www.vanguardngr.com/2016/03/17000-kidney-failure-cases-diagnosedannually-in-nigeria/. Accessed 07 June 2018.

  2. Khan S, Amedia CA. Economic burden of chronic kidney disease. J Eval Clin Pract. 2008;14:422–34.

    Article  PubMed  Google Scholar 

  3. Gasparini A, Wettermark B, Schmidt-Mende K, Evans M, Abdul Qureshi R, Peter Barany P, et al. Inappropriate prescription of nephrotoxic drugs to individuals with chronic kidney disease: a community-based analysis from the Stockholm Creatinine Measurements (Scream) Project. Nephrol Dial Transplant. 2017;32(Suppl_3) [Abstract].

  4. Hm H, Bjerke K, Holst L, Mathiesen L. Use of renal risk drugs in patients with renal impairment. Int J Clin Pharm. 2015. https://doi.org/10.1007/s11096-015-0175-3.

    Article  Google Scholar 

  5. Youssef A, Almubarak A, Aljohnai M, Alnuaimi M, Alshehri B, Al-ghamdi G, et al. Contraindicated medications administered to in-patients with renal insufficiency in a Saudi Arabian hospital that has a computerized clinical decision support system. J Taibah Univ Med Sci. 2015;10(3):320–6.

    Google Scholar 

  6. Ingrasciotta Y, Sultana J, Giorgianni F, Caputi AP, Arcoraci V, Tari DU, et al. The burden of nephrotoxic drug prescriptions in patients with chronic kidney disease: a retrospective population-based study in Southern Italy. PLoS ONE. 2014;9(2):e89072.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Chertow GM, Lee J, Kuperman GJ, Burdick E, Horsky J, Seger DL, et al. Guided medication dosing for in-patients with renal insufficiency. JAMA. 2001;286(22):2839–44.

    Article  CAS  PubMed  Google Scholar 

  8. Davis-Ajami ML, Fink JC, Wu J. Nephrotoxic medication exposure in U.S. adults with predialysis chronic kidney disease: health services utilization and cost outcomes. J Manag Care Spec Pharm. 2016;22:959–68.

    PubMed  Google Scholar 

  9. de Lusignan S, Chan T, Stevens P, O’Donoghue D, Hague N, Dzregah B, et al. Identifying patients with chronic kidney disease from general practice computer records. Fam Pract. 2005;22:234–41.

    Article  PubMed  Google Scholar 

  10. Kuo HW, Tsai SS, Tiao MM, Liu YC, Lee IM, Yang CY. Analgesic use and the risk for progression of chronic kidney disease. Pharmacoepidemiol Drug Saf. 2010;19(7):745–51.

    Article  PubMed  Google Scholar 

  11. Pannu N, Nadim MK. An overview of drug-induced acute kidney injury. Crit Care Med. 2008;36(4 Suppl):S216–23.

    Article  CAS  PubMed  Google Scholar 

  12. Wagner L, Asha L, Tata AL, Fink JC. Patient safety issues in CKD: core curriculum 2015. Am J Kidney Dis. 2015;66:159–69.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S, et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med. 2006;145(4):247–54.

    Article  CAS  PubMed  Google Scholar 

  14. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO. Clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2012;2013(3):1–150.

    Google Scholar 

  15. Naughton CA. Drug-induced nephrotoxicity. Am Fam Phys. 2008;78:743–50.

    Google Scholar 

  16. Bicalho MD, Soares DB, Botoni FA, Reis AM, Martins MA. Drug induced nephrotoxicity and dose adjustment recommendations: agreement among four drug information sources. Int J Environ Res Public Health. 2015;12:11227–40.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Akpan EE, Ekrikpo UE. Chronic kidney failure: knowledge of kidney disease, perception of causes and symptomatology in Uyo, Nigeria. Open J Nephrol. 2015;5:91–7.

    Article  Google Scholar 

  18. Oluyombo R, Ayodele OE, Akinwusi PO, Okunola OO, Gbadegesin BA, Soje MO, et al. Awareness, knowledge and perception of chronic kidney disease in a rural community of South-West Nigeria. Niger J Clin Pract. 2016;19:161–9.

    Article  CAS  PubMed  Google Scholar 

  19. Afolabi MO, Abioye-Kuteyi EA, Arogundade FA, Bello IS. Prevalence of chronic kidney disease in a Nigerian family practice population. SA Fam Pract. 2009;51(2):132–7.

    Google Scholar 

  20. Nalado AM, Abdu A, Muhammad H, Abdu A, Sakajiki AM, Adamu B. Prevalence of risk factors for chronic kidney disease among civil servants in Kano. Niger J Basic Clin Sci. 2012;9:70–4.

    Article  Google Scholar 

  21. Adibe MO, Ewelum PC, Amorha KC. Evaluation of drug–drug interactions among patients with chronic kidney disease in a South-Eastern Nigeria tertiary hospital: a retrospective study. Pan Afr Med J. 2017;28:199. https://doi.org/10.11604/pamj.2017.28.199.13622.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Alebiosu CO, Ayodele OO, Abbas A, Ina OA. Chronic renal failure at the Olabisi Onabanjo university teaching hospital, Sagamu, Nigeria. Afr Health Sci. 2006;6:132–8.

    PubMed  Google Scholar 

  23. Tabar P. Overuse of diuretics is common and risky for elderly. Advance Senior Care. June 25, 2013. https://www.advanceseniorcare.com. Accessed 08 June 2018.

  24. Khan YH, Sarriff A, Adnan AS, Khan AH, Mallhi TH. Chronic kidney disease, fluid overload and diuretics: a complicated triangle. PLoS ONE. 2016;11:1–13.

    CAS  Google Scholar 

  25. Ingrasciotta Y, Giorgianni F, Sultana J, Caputi AP, Savica V, Arcoraci V, et al. Use of nephrotoxic drugs in patients with chronic kidney disease: a population-based study in Southern Italy [Abstract]. https://congresso.sifweb.org/archivio/cong36/abs/126.pdf. Accessed 08 Aug 2018.

  26. Family Practice Notebook. Nephrotoxic Drug. https://www.fpnotebook.com. Accessed 07 June 2018.

  27. National Kidney Foundation. Gouty and hyperuricemia in chronic kidney: What is clinically significant? Hyperuricemia Bullettin. https://www.kidney.org/sites/default/02-10-6972%20Hyperuricemia%20Bulletin.pdf. Accessed 07 June 2018.

  28. Forgacs I, Loganayagam A. Overprescribing proton pump inhibitors. BMJ. 2008;336:2–3.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Klepser DG, Collier DS, Cochran GL. Proton pump inhibitors and acute kidney injury: a nested case-control study. BMC Nephrol. 2013;14:150.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Antoniou T, Hollands S, Gomes T, Mamdani MM, Garg AX, Paterson JM, Juurlink DN. Proton pump inhibitors and the risk of acute kidney injury in older patients: a population-based cohort study. CMAJ Open. 2015;3:E166–71.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Lazarus B, Chen Y, Wilson FP, Sang Y, Chang AR, Coresh J, Grams ME. Proton pump inhibitor use and the risk of chronic kidney disease. JAMA Intern Med. 2016;176:238–46.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Arora P, Gupta A, Golzy M, Patel N, Carter RL, Jalal K, et al. Proton pump inhibitors are associated with increased risk of development of chronic kidney disease. BMC Nephrol. 2016;17:112.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Xie Y, Bowe B, Li T, Xian H, Balasubramanian S, Al-Aly Z. Proton pump inhibitors and risk of incident CKD and progression to ESRD. J Am Soc Nephrol. 2016;27(10):3153–63.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Ishani A, Xue JL, Himmelfarb J, Eggers PW, Kimmel PL, Molitoris BA, et al. Acute kidney injury increases risk of ESRD among elderly. J Am Soc Nephrol. 2009;20:223–8.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Okusa MD, Chertow GM, Portilla D. The nexus of acute kidney injury, chronic kidney disease, and World Kidney Day 2009. Clin J Am Soc Nephrol. 2009;4:520–2.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Coca SG, Singanamala S, Parikh CR. Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis. Kidney Intern. 2012;81:442–8.

    Article  Google Scholar 

  37. Nderitu P, Doos L, Jones PW, Davies SJ, Kadam UT. Non-steroidal anti-inflammatory drugs and chronic kidney disease progression: a systematic review. Fam Pract. 2013;30(3):247–55.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The authors express their profound gratitude to the staff members of the medical records departments of the study hospitals for their technical support during data collection.

Funding

No special funding was received for this study.

Conflicts of interest

The authors declare no conflicts of interest.

Author information

Authors and Affiliations

  1. Department of Clinical Pharmacy and Pharmacy Administration, Faculty of Pharmacy, University of Maiduguri, Maiduguri, Nigeria

    Roland Nnaemeka Okoro & Victor Titus Farate

Authors
  1. Roland Nnaemeka Okoro
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Victor Titus Farate
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Roland Nnaemeka Okoro.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 28 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Okoro, R.N., Farate, V.T. The use of nephrotoxic drugs in patients with chronic kidney disease. Int J Clin Pharm 41, 767–775 (2019). https://doi.org/10.1007/s11096-019-00811-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11096-019-00811-9

Keywords

Search

Navigation